M&AHealthcareRUMOURED
GE HealthCare in talks over $1bn deal for maker of cancer scan chemicals
Value
$1.0Bn
Acquirer
GE HealthCare
Target
Sofie Biosciences
GE HealthCare is reportedly in negotiations to acquire Sofie Biosciences, a company specializing in cancer scan chemicals. This potential acquisition would be GE HealthCare's second significant purchase since its separation from General Electric.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.